These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38881606)
21. Response of Diabetic Macular Edema to Anti-VEGF Medications Correlates with Improvement in Macular Vessel Architecture Measured with OCT Angiography. Massengill MT; Cubillos S; Sheth N; Sethi A; Lim JI Ophthalmol Sci; 2024; 4(4):100478. PubMed ID: 38827030 [TBL] [Abstract][Full Text] [Related]
22. [Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema]. Yang XL; Zou HD; Xu X Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1081-8. PubMed ID: 24499694 [TBL] [Abstract][Full Text] [Related]
23. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272 [TBL] [Abstract][Full Text] [Related]
24. Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema. Carpineto P; Ciancaglini M; Di Antonio L; Gavalas C; Mastropasqua L Retina; 2007 Jan; 27(1):21-9. PubMed ID: 17218911 [TBL] [Abstract][Full Text] [Related]
26. Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration: A MACUSTAR Study Report. Dunbar HMP; Behning C; Abdirahman A; Higgins BE; Binns AM; Terheyden JH; Zakaria N; Poor S; Finger RP; Leal S; Holz FG; Schmid M; Crabb DP; Rubin GS; Luhmann UFO; JAMA Ophthalmol; 2022 Aug; 140(8):780-789. PubMed ID: 35737401 [TBL] [Abstract][Full Text] [Related]
27. Subthreshold Compared with Threshold Macular Photocoagulation for Diabetic Macular Edema: A Systematic Review and Meta-Analysis. Tai F; Nanji K; Garg A; Zeraatkar D; Phillips M; Steel DH; Garg SJ; Kaiser PK; Guymer RH; Wykoff CC; Sivaprasad S; Chaudhary V Ophthalmol Retina; 2024 Mar; 8(3):223-233. PubMed ID: 37805099 [TBL] [Abstract][Full Text] [Related]
28. Comparison of functional changes of retina after subthreshold and threshold pan-retinal photocoagulation in severe non-proliferative diabetic retinopathy. Zhao H; Zhou L; Lai K; Yu M; Huang C; Xu F; Li C; Lu L; Jin C Lasers Med Sci; 2022 Dec; 37(9):3561-3569. PubMed ID: 36070046 [TBL] [Abstract][Full Text] [Related]
29. Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy. Dervenis P; Dervenis N; Smith JM; Steel DH Cochrane Database Syst Rev; 2023 May; 5(5):CD008214. PubMed ID: 37260074 [TBL] [Abstract][Full Text] [Related]
30. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial. Scott IU; Jackson GR; Quillen DA; Larsen M; Klein R; Liao J; Holfort S; Munch IC; Gardner TW JAMA Ophthalmol; 2014 May; 132(5):535-43. PubMed ID: 24604308 [TBL] [Abstract][Full Text] [Related]
31. Twelve-month Natural History Study of Centrosomal Protein 290 (CEP290)-associated Inherited Retinal Degeneration. Pierce EA; Ashimatey BS; Jayasundera T; Hoyng C; Lam BL; Lorenz B; Kim K; Rashid A; Myers R; Pennesi ME Ophthalmol Sci; 2024; 4(5):100483. PubMed ID: 38881603 [TBL] [Abstract][Full Text] [Related]
32. Prediction of Function in ABCA4-Related Retinopathy Using Ensemble Machine Learning. Müller PL; Treis T; Odainic A; Pfau M; Herrmann P; Tufail A; Holz FG J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751377 [TBL] [Abstract][Full Text] [Related]
33. Longitudinal Quantitative Ultrawidefield Angiographic Features in Diabetic Retinopathy Treated with Aflibercept from the Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement Trial. Kalra G; Wykoff C; Martin A; Srivastava SK; Reese J; Ehlers JP Ophthalmol Retina; 2024 Feb; 8(2):116-125. PubMed ID: 37696393 [TBL] [Abstract][Full Text] [Related]
34. Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device. Zeng Y; Cao D; Yang D; Zhuang X; Yu H; Hu Y; Zhang Y; Yang C; He M; Zhang L Doc Ophthalmol; 2020 Jun; 140(3):211-220. PubMed ID: 31720980 [TBL] [Abstract][Full Text] [Related]
35. Longitudinal Study of Visual Function in Dry Age-Related Macular Degeneration at 12 Months. Hsu ST; Thompson AC; Stinnett SS; Luhmann UFO; Vajzovic L; Horne A; Schuman SG; Toth CA; Cousins SW; Lad EM Ophthalmol Retina; 2019 Aug; 3(8):637-648. PubMed ID: 31060977 [TBL] [Abstract][Full Text] [Related]
36. How to Achieve Near-Normal Visual Acuity with Bevacizumab in Diabetic Macular Edema Patients. Sędziak-Marcinek B; Wylęgała A; Chełmecka E; Wylęgała E; Teper S J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441868 [TBL] [Abstract][Full Text] [Related]
37. Longitudinal Evaluation of Visual Function Impairments in Early and Intermediate Age-Related Macular Degeneration Patients. Lad EM; Fang V; Tessier M; Rautanen A; Gayan J; Stinnett SS; Luhmann UFO Ophthalmol Sci; 2022 Sep; 2(3):100173. PubMed ID: 36245764 [TBL] [Abstract][Full Text] [Related]
39. Electroretinogram evaluation for the treatment of proliferative diabetic retinopathy by short-pulse pattern scanning laser panretinal photocoagulation. Ye H; Yu M; Lu L; Jin C; Luo G Lasers Med Sci; 2018 Jul; 33(5):1095-1102. PubMed ID: 29542045 [TBL] [Abstract][Full Text] [Related]